Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

OBJECTIVES: To evaluate the safety, pharmacokinetics, and preliminary efficacy of NT-814, a dual neurokinin 1,3 antagonist, in postmenopausal women with vasomotor symptoms (hot flashes). METHODS: We completed a double-blind, randomized, placebo-controlled trial in three US clinical research units in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Menopause
Auteurs principaux: Trower, Mike, Anderson, Richard A., Ballantyne, Elizabeth, Joffe, Hadine, Kerr, Mary, Pawsey, Steve
Format: Artigo
Langue:Inglês
Publié: Lippincott-Raven Publishers 2020
Sujets:
Original Studies
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188053/
https://ncbi.nlm.nih.gov/pubmed/32068688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001500
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires